ES2184844T3 - Procedimiento mejorado de sintesis de n-(3-(3-cianopirazolo(1,5-a)pirimidin-7-il)fenil)n-etilacetasmida. - Google Patents
Procedimiento mejorado de sintesis de n-(3-(3-cianopirazolo(1,5-a)pirimidin-7-il)fenil)n-etilacetasmida.Info
- Publication number
- ES2184844T3 ES2184844T3 ES96308630T ES96308630T ES2184844T3 ES 2184844 T3 ES2184844 T3 ES 2184844T3 ES 96308630 T ES96308630 T ES 96308630T ES 96308630 T ES96308630 T ES 96308630T ES 2184844 T3 ES2184844 T3 ES 2184844T3
- Authority
- ES
- Spain
- Prior art keywords
- phenyl
- ethylacetasmide
- cyanopirazol
- pyrimidin
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000003556 anti-epileptic effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
LA PRESENTE INVENCION ES UNA MEJORA EN LA PRODUCCION DE N-[3(3-CIANOPIRAZOL[1,5-A]PIRIMIDIN-7-IL)FENIL]-N-ETIL-ACETAMIDA, QUE ES UTIL COMO ANSIOLITICO, ANTIEPILEPTICO, AGENTE SEDANTEHIPNOTICO, Y RELAJANTE DEL MUSCULO ESQUELETICO. DICHA MEJORA CONSISTE EN HACER REACCIONAR 3-DIMETIL-AMINO-1-(3-N-ETIL-NACETILAMINOFENIL)-2-PROPEN-1-ONA, O UNA SAL ADECUADA DEL MISMO, CON 3-AMINOPIRAZOL-4-CARBONITRILO, O UNA SAL ADECUADA DEL MISMO, EN UNA MEZCLA QUE COMPRENDE AGUA Y ACIDO ACETICO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US785995P | 1995-12-01 | 1995-12-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2184844T3 true ES2184844T3 (es) | 2003-04-16 |
Family
ID=21728482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96308630T Expired - Lifetime ES2184844T3 (es) | 1995-12-01 | 1996-11-28 | Procedimiento mejorado de sintesis de n-(3-(3-cianopirazolo(1,5-a)pirimidin-7-il)fenil)n-etilacetasmida. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5714607A (es) |
| EP (1) | EP0776898B1 (es) |
| JP (1) | JP4112032B2 (es) |
| KR (1) | KR100439282B1 (es) |
| CN (1) | CN1057525C (es) |
| AR (1) | AR004822A1 (es) |
| AT (1) | ATE227290T1 (es) |
| AU (1) | AU718310B2 (es) |
| BR (1) | BR9605760A (es) |
| CA (1) | CA2191647C (es) |
| CY (1) | CY2440B1 (es) |
| CZ (1) | CZ292253B6 (es) |
| DE (1) | DE69624657T2 (es) |
| DK (1) | DK0776898T3 (es) |
| ES (1) | ES2184844T3 (es) |
| HU (1) | HU226398B1 (es) |
| IL (1) | IL119710A (es) |
| MX (1) | MX9605974A (es) |
| NO (1) | NO307181B1 (es) |
| NZ (1) | NZ299848A (es) |
| PT (1) | PT776898E (es) |
| RU (1) | RU2178415C2 (es) |
| SK (1) | SK281807B6 (es) |
| TW (1) | TW382629B (es) |
| ZA (1) | ZA9610008B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6399621B1 (en) | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| US6485746B1 (en) | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
| US20030091632A1 (en) * | 1999-08-26 | 2003-05-15 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
| US6384221B1 (en) | 1999-09-02 | 2002-05-07 | Neurocrine Biosciences, Inc. | Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| NZ527455A (en) * | 2000-08-03 | 2005-07-29 | Wyeth Corp | Polymorphs of zaleplon and methods for the preparation thereof |
| EP1526136A1 (en) * | 2000-08-03 | 2005-04-27 | Wyeth | Polymorphs of zaleplon and methods for the preparation thereof |
| AR029780A1 (es) | 2000-12-13 | 2003-07-16 | Gador Sa | Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida |
| US20050032818A1 (en) * | 2001-06-12 | 2005-02-10 | Entire Interest | N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon |
| HRP20040016A2 (en) * | 2001-06-12 | 2004-10-31 | Biogal Gyogyszergyar | Process for the production of n-[3-[3-cyanopyrazolo [1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon) |
| MXPA04001035A (es) | 2001-08-01 | 2004-06-22 | Biogal Gyogyszergyar | Proceso para purificar n-[3-(3-cianopirazolo[1,5-a]pirimidin-7-il)fenil]-n-etilacetamida (zaleplon) y formas cristalinas de zaleplon accesibles con este proceso. |
| WO2003068775A1 (de) * | 2002-02-14 | 2003-08-21 | Cilag Ag | VERFAHREN ZUR HERSTELLUNG VON N-ETHYL-N-`3-(3-CYANOPYRAZOLO `1,5-A!PYRIMIDIN-7-YL}ACETAMID |
| ZA200406577B (en) * | 2002-02-15 | 2006-06-28 | Teva Gyogyzeryan Reszvenytarsa | Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom |
| PL207322B1 (pl) * | 2002-05-14 | 2010-11-30 | Adamed Społka Z Ograniczoną Odpowiedzialnością | Sposób wytwarzania zaleplonu |
| DE112004001615T5 (de) | 2003-09-04 | 2006-06-14 | Cipla Ltd. | Zaleplon-Synthese |
| WO2005060968A1 (en) | 2003-12-11 | 2005-07-07 | Sepracor Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| AU2004314335A1 (en) * | 2004-01-14 | 2005-08-04 | Mallinckrodt Inc. | Two-phase method for the synthesis of selected pyrazolopyrimidines |
| HUP0400325A3 (en) | 2004-02-02 | 2005-11-28 | Richter Gedeon Vegyeszet | Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates |
| CA2556870C (en) | 2004-02-18 | 2014-01-28 | Timothy J. Barberich | Dopamine-agonist combination therapy for improving sleep quality |
| WO2006070244A2 (en) * | 2004-11-22 | 2006-07-06 | Bakulesh Mafatlal Khamar | A process for the preparation of zaleplon |
| WO2008021309A1 (en) * | 2006-08-15 | 2008-02-21 | Wyeth | Imidazolidin-2-one derivatives useful as pr modulators |
| TW200815428A (en) * | 2006-08-15 | 2008-04-01 | Wyeth Corp | Oxazolidone derivatives as PR modulators |
| WO2008021337A1 (en) | 2006-08-15 | 2008-02-21 | Wyeth | Oxazinan-2-one derivatives useful as pr modulators |
| US7649007B2 (en) * | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
| WO2008068600A2 (en) * | 2006-12-06 | 2008-06-12 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of zaleplo |
| CZ301145B6 (cs) | 2008-07-31 | 2009-11-18 | Farmak, A. S. | Zpusob prípravy N-(1-benzo[b]thien-2-ylethyl)-N-hydroxymocoviny |
| CN102816163A (zh) * | 2012-08-20 | 2012-12-12 | 四川禾邦阳光制药股份有限公司 | 扎来普隆的新晶型及制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3907799A (en) * | 1971-08-16 | 1975-09-23 | Icn Pharmaceuticals | Xanthine oxidase inhibitors |
| US4281000A (en) * | 1979-07-09 | 1981-07-28 | American Cyanamid Company | Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents |
| US4626538A (en) * | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
| NZ208554A (en) * | 1983-06-23 | 1987-06-30 | American Cyanamid Co | (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions |
| US4521422A (en) * | 1983-06-23 | 1985-06-04 | American Cyanamid Company | Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
| JPS62270584A (ja) * | 1986-04-28 | 1987-11-24 | Yoshitomi Pharmaceut Ind Ltd | ４，７−ジヒドロピラゾロ〔１，５−ａ〕ピリミジン誘導体 |
| RO108347B1 (ro) * | 1989-10-30 | 1994-04-28 | Bellon Labor Sa Roger | DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA |
| US5356897A (en) * | 1991-09-09 | 1994-10-18 | Fujisawa Pharmaceutical Co., Ltd. | 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines |
| GB9321162D0 (en) * | 1993-10-13 | 1993-12-01 | Boots Co Plc | Therapeutic agents |
-
1996
- 1996-11-25 US US08/758,132 patent/US5714607A/en not_active Expired - Lifetime
- 1996-11-28 HU HU9603275A patent/HU226398B1/hu unknown
- 1996-11-28 AT AT96308630T patent/ATE227290T1/de active
- 1996-11-28 IL IL11971096A patent/IL119710A/xx not_active IP Right Cessation
- 1996-11-28 NO NO965084A patent/NO307181B1/no not_active IP Right Cessation
- 1996-11-28 DK DK96308630T patent/DK0776898T3/da active
- 1996-11-28 PT PT96308630T patent/PT776898E/pt unknown
- 1996-11-28 DE DE69624657T patent/DE69624657T2/de not_active Expired - Lifetime
- 1996-11-28 ZA ZA9610008A patent/ZA9610008B/xx unknown
- 1996-11-28 EP EP96308630A patent/EP0776898B1/en not_active Expired - Lifetime
- 1996-11-28 ES ES96308630T patent/ES2184844T3/es not_active Expired - Lifetime
- 1996-11-29 CZ CZ19963505A patent/CZ292253B6/cs not_active IP Right Cessation
- 1996-11-29 NZ NZ299848A patent/NZ299848A/en not_active IP Right Cessation
- 1996-11-29 SK SK1536-96A patent/SK281807B6/sk not_active IP Right Cessation
- 1996-11-29 AR ARP960105438A patent/AR004822A1/es active IP Right Grant
- 1996-11-29 KR KR1019960059652A patent/KR100439282B1/ko not_active Expired - Fee Related
- 1996-11-29 JP JP31909596A patent/JP4112032B2/ja not_active Expired - Fee Related
- 1996-11-29 CA CA002191647A patent/CA2191647C/en not_active Expired - Fee Related
- 1996-11-29 TW TW085114751A patent/TW382629B/zh not_active IP Right Cessation
- 1996-11-29 BR BR9605760A patent/BR9605760A/pt not_active Application Discontinuation
- 1996-11-29 RU RU96122857/04A patent/RU2178415C2/ru not_active IP Right Cessation
- 1996-11-29 AU AU74091/96A patent/AU718310B2/en not_active Ceased
- 1996-11-29 MX MX9605974A patent/MX9605974A/es unknown
- 1996-11-30 CN CN96118985A patent/CN1057525C/zh not_active Expired - Fee Related
-
2004
- 2004-05-06 CY CY0400035A patent/CY2440B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9906287A (pt) | Bactéria pertencente ao gênero escherichia e que tem uma capacidade para produzir um l-aminoácido, e, processo para produzir um l-aminoácido | |
| EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
| IL134142A0 (en) | Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions | |
| BR9906903A (pt) | Composição com liberação sustentada, processos para produzir a mesma, para suprimir a brusca liberação inicial da susbtância bioativa de uma composição com liberação sustentada e para aumentar a eficiência da inclusão da substância bioativa em uma composição com liberação sustentada, produto farmacêutico, agente para prevenir ou tratar câncer prostático, hipertrofia prostática, endometriose, histeromioma, metrofibroma, puberdade precoce, dismenorréia, ou câncer do seio, ou um contraceptivo, e, composto | |
| IL177228A0 (en) | Use of a vector for the manufacture of a medicament for treating gaucher disease | |
| DE69530933D1 (de) | Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis | |
| AR004822A1 (es) | Proceso mejorado en la produccion de n-[3-[3-cianopirazolo[1,5-a]pirimidin- 7-il)fenil]-n-etil-acetamida | |
| LT2000087A (lt) | Dezinfekavimo kompozicija | |
| SV1996000008A (es) | Uso de amidas de acido fenilciclohexilcarboxilicos | |
| FR2630725B1 (fr) | Procede de preparation du chlorure ferrique a partir du chlorure ferreux | |
| TW267161B (es) | ||
| AR004093A1 (es) | El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas. | |
| ES2038642T3 (es) | Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel. | |
| GB8913879D0 (en) | Hair treatment composition | |
| TR199802601A2 (xx) | Susuz Sodyum S�lf�r�n Haz�rlanma Y�ntemi | |
| DK325387D0 (da) | 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid samt dets fremstilling og anvendelse | |
| ES2169124T3 (es) | Acido 4-aminomicofenolico 6-sustituido y derivados con actividad inmunosupresora. | |
| ES2159967T3 (es) | Medicamento que contiene acido delta-aminolevulinico. | |
| DE68921051D1 (de) | Pyridin-3-percarboxylsäure monopersulfat. | |
| EP0734255A4 (en) | NEW POTASSIUM CHANNEL AGONIST RECEIVED BY TRICHODERMA VIRENS | |
| BR0207953A (pt) | Derivados de caloporosida, processos para a sua preparação e sua aplicação | |
| GR74756B (es) | ||
| BR9611805A (pt) | Derivados de amino álcool processos para a sua produção e agentes farmacêuticos contendo estes compostos | |
| SE9002537D0 (sv) | Anordning foer matning av gjutgods | |
| SU1769538A1 (ru) | Средство для дубления кож |